ANTIGON
Curator
1 mandateCurator, Chaussee De Thuin 164, 6032 Mont-Sur-Marchienne
from 06-02-2023 to 15-07-2025
Also on 121 other cases
Last board
5 directors, last change in 2022BT LIFE SCIENCE SRL
Director, permanent representative Thierry BALTUS
in office according to the deed of 09-12-2022
6-year term from 2022
PHARBIOMED SRL
Director, permanent representative Hanane EL KENZ
in office according to the deed of 09-12-2022
6-year term from 2022
Sambrinvest spin-off/spin-out
Director, permanent representative Helena POZIOS
in office according to the deed of 09-12-2022
6-year term from 2022
Permanent representatives 3
Hanane EL KENZ
Permanent representative, for PHARBIOMED SRL
in office according to the deed of 09-12-2022
Helena POZIOS
Permanent representative, for Sambrinvest spin-off/spin-out
in office according to the deed of 09-12-2022
Thierry BALTUS
Permanent representative, for BT LIFE SCIENCE SRL
in office according to the deed of 09-12-2022
Mandates through the years
7 names, the dashed line is todayBT LIFE SCIENCE SRL
Director
Director
PHARBIOMED SRL
Director
Director
Terry MORO
Director
Director
Sambrinvest spin-off/spin-out
Director
Director
THEODORUS III
Director
Director
THOMAS LIENARD SRL
Director
Director
Alexandre Chau
Independent director
Independent director
BoardEarlierend not datedBankruptcy 06-02-2023
Mandates as a list
- BT LIFE SCIENCE SRL
- Director, from 11-07-2016, until the bankruptcy of 06-02-2023
- Managing director, appointed by deed of 30-10-2018, last mentioned in 2018
- PHARBIOMED SRL
- Director, from 11-07-2016, until the bankruptcy of 06-02-2023
- Terry MORO
- Director, from 11-07-2016, until the bankruptcy of 06-02-2023
- Sambrinvest spin-off/spin-out
- Director, from 28-02-2019, until the bankruptcy of 06-02-2023
- THEODORUS III
- Director, from 26-06-2020, until the bankruptcy of 06-02-2023
- THOMAS LIENARD SRL
- Director, appointed by deed of 09-09-2020, last mentioned in 2020
- Alexandre Chau
- Independent director, appointed by deed of 30-10-2018, no longer listed in the 2021 annual accounts
Control
Shareholder
Equity €163,489
Profit €28.4m in 2024 (loss €544,396 in 2023)
Checked score 24
27.78%
This company
ANTIGON
Equity €1.6m
Loss €699,512 in 2021
Capital
- Capital
- €3,272,637.50
- Shares
- 79,200 in the deed of 03-04-2020 and 1 later capital increase
- Contribution per share
- €41.32
- Equity per share
- €20.56 in 2021
- Source
- deed of 05-08-2021
Owners through the years
as the annual accounts name themOwners as a list
- FONDS DE CAPITAL A RISQUE 2020
- Carbon Spin Off / Spin Out
- THEODORUS III
Source: lists of holdings in the owners' accounts
Articles of association
deed of 03-04-2020 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 5 directors“Sur proposition des actionnaires de Classe A/B”
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Second Tuesday of June at 10:00
Shareholders
3 ownersOwners 3
- Equity €163,489 Profit of €28.4m in 2024 (loss of €544,396 in 2023) Checked score 2427.78%
- Equity €41.6m Profit of €8.5m in 2025 (loss of €3.3m in 2024)18.78%
- Equity €37.5m Profit of €2.1m in 2025 (profit of €2.3m in 2024)11.74%
Capital transactions
Capital over time
- 05-08-2021 Capital increase of €745,000 · to €3,272,637.50 · 14,900 new shares at €50 per share · in cash
- 03-04-2020 Capital increase of €1,025,000 · to €2,527,637.50 · 20,500 new shares at €50 per share, 31.9% of the 64,300 shares after the increase · in cash
- 01-08-2019 Capital increase of €716,250 · to €1,502,625 · 14,325 new shares at €50 per share
- 01-08-2019 Capital increase of €12.50 · to €1,502,637.50 · 1,250 new shares at €0.01 per share · in cash